Dietary advanced glycation end products modify gut microbial composition and partially increase colon permeability in rats

Mol Nutr Food Res. 2017 Oct;61(10). doi: 10.1002/mnfr.201700118. Epub 2017 Jul 31.

Abstract

Scope: The adverse impacts of dietary advanced glycation end products (AGEs) on health are currently of interest. These compounds are inevitably formed during thermal food processing and make foods less digestible because of protein cross-linking. This study examined not only whether dietary AGEs alter cecal microbiota and their metabolites but also their effects on colon permeability.

Methods and results: Sprague-Dawley rats were exposed to a high-AGEs diet (AGEs content was increased by heating food at 125°C/3 h) for 6, 12, or 18 weeks. Cecal microbiota was analyzed by 16S rDNA gene sequencing. Colon permeability was assessed through histopathology, immunohistochemistry and endotoxin testing. Microbial metabolites (e.g. ammonia and short-chain fatty acids (SCFAs)) were also measured. AGEs treatment reduced the diversity and richness of the microbiota, especially saccharolytic bacteria such as Ruminococcaceae and Alloprevotella, which can produce SCFAs, whereas some putatively harmful bacteria (Desulfovibrio and Bacteroides) were increased. Protein fermentation was enhanced, supported by elevated ammonia and branched-chain fatty acid levels (p < 0.05). Additionally, the colonocytes structure changed and the expression of tight junction proteins in colon were decreased.

Conclusion: Dietary AGEs detrimentally modulate gut microbial ecology and may partially increase colon permeability, which can adversely impact host health.

Keywords: Advanced glycation end products (AGEs); Cecal microbiota; Colon permeability; Dietary; Microbial metabolite.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Ammonia / metabolism
  • Animals
  • Bacteroidetes / drug effects
  • Bacteroidetes / isolation & purification
  • Colon / drug effects*
  • Colon / metabolism
  • Colon / microbiology
  • Cyanobacteria / drug effects
  • Cyanobacteria / isolation & purification
  • DNA, Bacterial / genetics
  • Diet*
  • Fatty Acids, Volatile / metabolism
  • Fermentation
  • Firmicutes / drug effects
  • Firmicutes / isolation & purification
  • Gastrointestinal Microbiome / drug effects*
  • Glycation End Products, Advanced / pharmacology*
  • Male
  • Occludin / genetics
  • Occludin / metabolism
  • Permeability
  • Proteobacteria / drug effects
  • Proteobacteria / isolation & purification
  • RNA, Ribosomal, 16S / genetics
  • Rats
  • Rats, Sprague-Dawley
  • Sequence Analysis, DNA
  • Verrucomicrobia / drug effects
  • Verrucomicrobia / isolation & purification
  • Zonula Occludens-1 Protein / genetics
  • Zonula Occludens-1 Protein / metabolism

Substances

  • DNA, Bacterial
  • Fatty Acids, Volatile
  • Glycation End Products, Advanced
  • Occludin
  • Ocln protein, rat
  • RNA, Ribosomal, 16S
  • Tjp1 protein, rat
  • Zonula Occludens-1 Protein
  • Ammonia